Source: Owler

Theravance Biopharma, Inc.: Theravance Biopharma's revenue changed from $62.02M in Jun 2024 to $63.19M in Sep 2024

Theravance Biopharma’s Trailing Twelve Months revenue changed from $62.02M in Jun 2024 to $63.19M in Sep 2024 increasing 1.9% in this time period.

Read full article »
Annual Revenue
$25-100M
Employees
25-100
Rick E. Winningham's photo - Chairman & CEO of Theravance Biopharma

Chairman & CEO

Rick E. Winningham

CEO Approval Rating

90/100

Read more